Search results
Results from the WOW.Com Content Network
As of 2022, the speciality chemicals contributed 33% of Jubilant Ingrevia's revenue, nutrition and health solutions contributed 18% and life science chemicals contributed 49%. [ 16 ] As of 2022, Jubilant Ingrevia is the world's lowest cost producer of pyridine -based derivative products, one of the two producers of pyridine and a leader in 14 ...
Vitamin D is a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, magnesium, and phosphate, along with numerous other biological functions. [1] [2] In humans, the most significant compounds within this group are vitamin D 3 (cholecalciferol) and vitamin D 2 (ergocalciferol). [2] [3]
In 2011, the Supreme Court of India issued a contempt notice to DS Group for violating its order against using plastic sachets to sell products. The company attempted to bypass the Supreme Court's ban on selling products in plastic pouches by falsely labeling them as "only for export", despite being sold domestically at a price of ₹6.
Here are four ways getting more vitamin D can help in menopause. Bone Health: Menopause does a number on our bones because it decreases the amount of calcium our bodies can absorb. Likewise, low ...
In addition to its vitamin D content, trout is packed with high-quality protein and heart-healthy omega-3 fatty acids, which can help fight inflammation and support cardiovascular health. Trout ...
22-Dihydroergocalciferol is a form of vitamin D, also known as vitamin D 4. [2] It has the systematic name (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-ergostatrien-3-ol. [1] Vitamin D 4 is found in certain mushrooms, being produced from ergosta-5,7-dienol (22,23-dihydroergosterol) instead of ergosterol. [3]
For premium support please call: 800-290-4726 more ways to reach us
Alembic has two research and development (R&D) centres which have been well supported by Alembic for its growth initiatives. The company has spent much of its capital on R&D, with majority of expenses on R&D for its markets in the US. [7] For the FY2015-2016, Alembic Pharmaceuticals invested ₹346 crore in R&D alone with 470 on-going projects. [3]